<DOC>
	<DOCNO>NCT00675792</DOCNO>
	<brief_summary>The primary purpose study compare incidence residual neuromuscular blockade time tracheal extubation reversal rocuronium bromide-induced neuromuscular blockade 4 mg/kg sugammadex 50 µg/kg neostigmine . Residual neuromuscular blockade define fourth twitch first twitch ( T4/T1 ) ratio &lt; 0.90 .</brief_summary>
	<brief_title>Comparison Sugammadex Administered 1-2 Post Tetanic Counts ( PTCs ) Better With Neostigmine Administered Per Standard Care Reverse Rocuronium-Induced Neuromuscular Blockade Adults Undergoing Elective Open Abdominal Procedure ( 19.4.334 ) ( P05774 )</brief_title>
	<detailed_description>Undetected residual neuromuscular blockade common post-anesthesia care unit ( PACU ) . In fact , 16 % -42 % patient receive intermediate-acting muscle relaxant operate room T4/T1 ratio &lt; 0.7-0.8 PACU . Respiratory pharyngeal muscle function adversely affect minimal neuromuscular blockade . Studies awake volunteer surgical patient demonstrate T4/T1 ratio 0.7 - 0.9 associate impaired airway protective reflex , upper airway obstruction , decrease hypoxic ventilatory response , post-operative hypoxemia . The incidence severity residual neuromuscular blockade time tracheal extubation evaluate determine influence length stay operate room PACU .</detailed_description>
	<mesh_term>Neostigmine</mesh_term>
	<mesh_term>Rocuronium</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>male female &gt; = 18 &lt; = 65 year age classify American Society Anesthesiologists ( ASA ) Class 1 2 3 ; Body Mass Index ( BMI ) &lt; 35 kg/m^2 ; schedule undergo elective open abdominal surgical procedure general anesthesia require neuromuscular relaxation use rocuronium bromide ( maintenance neuromuscular blockade require ) endotracheal intubation require neuromuscular blockade reversal ; schedule undergo surgical procedure position interfere use TOFWatch® SX ; schedule undergo elective open abdominal procedure expect last &lt; =4 hour ( start skin incision end last stitch skin ) ; give write informed consent . participant difficult intubation expect anatomical malformation ; know suspect neuromuscular disorder may impair neuromuscular blockade ; know suspect significant renal dysfunction ( e.g. , creatinine clearance &lt; 30 mL/min ) ; know suspect significant hepatic dysfunction ; know suspect ( family ) history malignant hyperthermia ; know suspect allergy opioids , muscle relaxant medication use general anesthesia ; participant use neostigmine and/or glycopyrrolate may contraindicate ; participant preestablished need postoperative intensive care admission expect ; pregnant breastfeeding female ; participate previous sugammadex clinical trial ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>